Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125289341 | 12528934 | 1 | I | 20160509 | 20160705 | 20160705 | EXP | PHHY2016TR065933 | SANDOZ | TABAKCI MM, TOPRAK C, AVCI A, KARGIN R. A CASE OF HYPERTENSIVE FIBRO MUSCULAR DYSPLASIA LEADING TO ABORTUS. KO?UYOLU HEART JOURNAL. 2016;19(1):58-9 | 26.00 | YR | F | Y | 0.00000 | 20160705 | OT | TR | TR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125289341 | 12528934 | 1 | SS | LOPRESSOR | METOPROLOL TARTRATE | 1 | Unknown | 50 MG, UNK | 0 | 50 | MG | ||||||||
125289341 | 12528934 | 2 | PS | METHYLDOPA. | METHYLDOPA | 1 | Unknown | 1500 MG, UNK | 18934 | 1500 | MG | ||||||||
125289341 | 12528934 | 3 | SS | NIFEDIPINE. | NIFEDIPINE | 1 | Unknown | 60 MG, UNK | 0 | 60 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125289341 | 12528934 | 1 | Hypertension |
125289341 | 12528934 | 2 | Hypertension |
125289341 | 12528934 | 3 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125289341 | 12528934 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125289341 | 12528934 | Abortion spontaneous | |
125289341 | 12528934 | Hypertension | |
125289341 | 12528934 | Maternal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |